Our fundamental purpose is to positively impact patients' lives, offering them hope, support, and access to the latest scientific discoveries in the fight against this devastating disease. One of the main objectives of the Cura Project Institute is to make society aware of the benefits of research in confronting cancer. Awareness is the first step towards information, and that is why we commit to holding events, actions, and campaigns to educate the public about the fundamental role of clinical research in the search for lasting solutions to cancer.
Attend our events, follow our Social Networks and stay informed. We are committed to our mission to support and promote clinical cancer research, as we believe that it is through it that we can truly make a difference and save lives.
Inspire others in the fight against cancer. Share your story of overcoming with us! If you've ever overcome cancer or followed someone who went through this journey closely, we want to hear from you and tell your story!
For this we need a lot of awareness, education and investments. The main challenge of the Cura Project Institute is to sensitize society to the fact that cancer is currently our greatest enemy at the global level. A series of initiatives are being implemented to place Latin America on the world map of cancer research: the Cura Project Institute is one of them.
Primary objectives: To evaluate in a phase III randomized clinical trial the comparison between an anthracycline-initiated neoadjuvant chemotherapy (AC-T) versus a taxane-initiated (T-AC) regimen in patients with locally advanced HER2 breast cancer
Primary objectives: To evaluate in a phase III randomized clinical trial the comparison between an anthracycline-initiated neoadjuvant chemotherapy (AC-T) versus a taxane-initiated (T-AC) regimen in patients with locally advanced HER2 breast cancer
Primary objectives: To compare overall survival for individuals treated with docetaxel versus individuals treated with docetaxel plus Radio-223.
Primary objectives: To describe the demographic and clinical characteristics of a real-world cohort of Brazilian patients diagnosed with ES-SCLC treated with durvalumab-based regimens.
Primary objectives: To describe the clinical characteristics, treatment patterns, and outcomes of patients with pancreatic, gastric, and gastroesophageal junction cancer in Latin America
Describe the epidemiological characteristics and prognostic factors for disease-free survival of patients with CC with and without HIV infection.
Primary objectives: To describe epidemiological characteristics, molecular profile, treatment patterns, and outcomes of endometrial cancer in a Brazilian population
Primary objectives: To evaluate the efficacy of the extreme hypofractionation scheme, in 5 fractions of 5.2 Gy, in women with breast cancer.
Primary objectives: To evaluate the pCR rate in participants with HER2-positive early breast cancer selected for high dependence on the HER2 pathway and treated with neoadjuvant PHESGO without chemotherapy; who demonstrate a favorable PET-CT response after the third cycle of therapy.
Primary objectives: To evaluate the safety profile, including dose modifications, of nirparib in patients with advanced ovarian cancer in response after platinum-based first-line chemotherapy treated in a real-world environment within the EAP.
It is through clinical research that medicine evolves. Research is essential so that we can learn more about diseases, develop new drugs, vaccines, and tests.
Find out if there are any open clinical studies that consider the characteristics of your disease. Talk to your doctor to find out if treatment is available through a clinical trial.
There are some platforms, sites, and research dissemination profiles. O @projetocura @lacogcancerresearch And the @pesquisaclinicacancer they always publish open studies.
Follow CURA on social media
© 2023 Cura Project Institute. All rights reserved.
.jpeg)
